Children younger than 3 years who have parasitemia above 100 000 × 106/L without developing a hemoglobin level less than 60 g/L (6 g/dL)
. | . | . | . | . | . | . | . | . | Hb, g/L . | . | . | . | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient identifier . | Age, y . | Sex . | Site . | Hb type . | G-6-PD . | Infected RBCs × 106/L (%) . | Treatment . | Treatment failure . | Baseline . | At treatment . | Lowest . | Time to lowest . | |||
| 111015 | 0.63 | M | D | AA | Normal | 119 000 (3.7) | P/Su | No | 109 | 104 | 92 | 3 d | |||
| 110997 | 1.1 | F | D | AC | Normal | 204 000 (6.3) | Q,C | Yes | 107 | 103 | 83 | 11 d | |||
| 110730 | 1.5 | M | D | AA | Normal | 110 000 (3.6) | Q | No | 114 | 98 | 84 | 14 d | |||
| 110991 | 1.4 | M | D | AA | Normal | 196 000 (5.6) | P/Su | No | 103 | 112 | 82 | 3 d | |||
| 110272 | 1.8 | F | D | AA | Unknown | 108 000 (3.3) | P/Su | Yes | 125 | 106 | 91 | 3 d | |||
| 110978 | 2.3 | M | D | AA | Normal | 110 000 (3.2) | Q | No | 116 | 110 | 95 | 7 d | |||
| 110251 | 2.5 | M | D | AA | Normal | 246 000 (8.4) | P/Su | No | 124 | 94 | 97 | 7 d | |||
| 110609 | 2.9 | M | D | AA | Normal | 205 000 (6.8) | P/Su | No | 112 | 96 | 88 | 3 d | |||
| 110070 | 2.9 | M | D | AA | Normal | 134 000 (4.6) | P/Su | Yes | 113 | 93 | 82 | 3 d | |||
| 110305 | 2.9 | M | D | AA | Normal | 123 100 (3.6) | P/Su | No | 105 | 107 | 96 | 3 d | |||
| 110968 | 2.4 | M | D | AA | Normal | 121 875 (3.9) | Q | No | 123 | 100 | 89 | 3 d | |||
| 110983 | 0.8 | M | D | AA | Normal | 103 050 (3.3) | P/Su | No | 106 | 101 | 76 | 7 d | |||
| 210029 | 2.3 | F | S | AS | Normal | 149 000 (5.1) | P/Su | Yes | 107 | 92 | 81 | 7 d | |||
| 210286 | 2.8 | M | S | AA | Normal | 127 000 (3.8) | P/Su | No | 113 | 108 | 80 | 14 d | |||
. | . | . | . | . | . | . | . | . | Hb, g/L . | . | . | . | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient identifier . | Age, y . | Sex . | Site . | Hb type . | G-6-PD . | Infected RBCs × 106/L (%) . | Treatment . | Treatment failure . | Baseline . | At treatment . | Lowest . | Time to lowest . | |||
| 111015 | 0.63 | M | D | AA | Normal | 119 000 (3.7) | P/Su | No | 109 | 104 | 92 | 3 d | |||
| 110997 | 1.1 | F | D | AC | Normal | 204 000 (6.3) | Q,C | Yes | 107 | 103 | 83 | 11 d | |||
| 110730 | 1.5 | M | D | AA | Normal | 110 000 (3.6) | Q | No | 114 | 98 | 84 | 14 d | |||
| 110991 | 1.4 | M | D | AA | Normal | 196 000 (5.6) | P/Su | No | 103 | 112 | 82 | 3 d | |||
| 110272 | 1.8 | F | D | AA | Unknown | 108 000 (3.3) | P/Su | Yes | 125 | 106 | 91 | 3 d | |||
| 110978 | 2.3 | M | D | AA | Normal | 110 000 (3.2) | Q | No | 116 | 110 | 95 | 7 d | |||
| 110251 | 2.5 | M | D | AA | Normal | 246 000 (8.4) | P/Su | No | 124 | 94 | 97 | 7 d | |||
| 110609 | 2.9 | M | D | AA | Normal | 205 000 (6.8) | P/Su | No | 112 | 96 | 88 | 3 d | |||
| 110070 | 2.9 | M | D | AA | Normal | 134 000 (4.6) | P/Su | Yes | 113 | 93 | 82 | 3 d | |||
| 110305 | 2.9 | M | D | AA | Normal | 123 100 (3.6) | P/Su | No | 105 | 107 | 96 | 3 d | |||
| 110968 | 2.4 | M | D | AA | Normal | 121 875 (3.9) | Q | No | 123 | 100 | 89 | 3 d | |||
| 110983 | 0.8 | M | D | AA | Normal | 103 050 (3.3) | P/Su | No | 106 | 101 | 76 | 7 d | |||
| 210029 | 2.3 | F | S | AS | Normal | 149 000 (5.1) | P/Su | Yes | 107 | 92 | 81 | 7 d | |||
| 210286 | 2.8 | M | S | AA | Normal | 127 000 (3.8) | P/Su | No | 113 | 108 | 80 | 14 d | |||
Abbreviations and treatments are explained in Table 1.